Clinical Trial

Global Reference Ranges - Singapore

Study acronym: GRR Singapore
Recruiting
View on ClinicalTrials.gov →
Summary
We aim to undertake the Global Reference Range Study (GRR) to establish a set of healthy adult reference values for measures of fibroinflammation, fat and size/volumes for the liver, and other abdominal and thoracic organs to assess, compare, and if necessary, propose ethnicity specific reference ranges for these measurements.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-03; most recent amendment 2026-07-13.
Status change: Not Yet Recruiting → Recruiting 2026-07-13
Trial Details
NCT Number NCT07166471
Lead Sponsor Perspectum
Collaborators: National Heart Centre Singapore
Conditions Healthy Participants
Enrollment 50 participants
Start Date 2026-01-01
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-15